'I thought I had won': Mother, 34, who was given the all-clear from 'one in a million' cancer tragically reveals the tumour has returned - and is now terminal
Stephanie Thomson, 34, previously hit the headlines after documenting her battle with extrarenal rhabdoid tumours, a 'one in ...
Lupus Foundation of America14d
FDA Approves a Phase 1 Trial for Investigational Therapy, CB-010, for Lupus Nephritis Treatment
The U.S. Food & Drug Administration has granted approval for a Phase 1 study to evaluate the safety and efficacy of ...
Medscape3d
Managing End-Stage Renal Disease in the Elderly
Choosing the Most Appropriate Treatment Option in Elderly Patients With ESRD Once an elderly patient receives a diagnosis of CKD, physicians are asked to make choices about the future management ...
Medscape1mon
The Vitamin D–antimicrobial Peptide Pathway and Its Role in Protection against Infection
Extrarenal production of active vitamin D in immune cells is important for optimal immune response. Vitamin D modulates T-cell responses and has anti-inflammatory properties, but boosts innate ...
Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting
Key Therapeutic Mechanisms of Clinical Activity for Autoimmune Diseases, including B cell Depletion, Tissue Infiltration and ...
Business Insider29d
Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in Lupus
FDA has cleared Caribou’s IND application for CB-010 in lupus nephritis and extrarenal lupus; GALLOP Phase 1 clinical trial expected to initiate by YE 2024 -- -- Driven by encouraging initial ...
Paisley mum battling rare cancer feels she's been handed 'death sentence' after refusal from medical trials
Lanarkshire toddler diagnosed with cancer after parents noticed she was ‘constantly unwell’ The Paisley Daily Express reports ...
University of Sheffield12mon
Abdominal imaging
to inform progression Identifying a prognostic signature for patients with rapidly progressive ADPKD involving functional MRI techniques Evaluating treatment for ADPKD Studies on extrarenal ...
Yahoo Finance29d
Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in Lupus
and extrarenal lupus (ERL). The Phase 1, multicenter, open label GALLOP clinical trial of CB-010 in patients with LN and ERL is expected to initiate by year-end 2024. “CB-010 has demonstrated ...
Morningstar11d
Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting
including lupus nephritis and extrarenal lupus (NCT06308978). In addition, the Company will highlight preclinical data from its off-the-shelf, iPSC-derived, CAR T-cell product platform for solid ...
Stockhouse11d
Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting
including lupus nephritis and extrarenal lupus (NCT06308978). In addition, the Company will highlight preclinical data from its off-the-shelf, iPSC-derived, CAR T-cell product platform for solid ...
Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in Lupus
FDA has cleared Caribou’s IND application for CB-010 in lupus nephritis and extrarenal lupus; GALLOP Phase 1 clinical trial expected to initiate by YE 2024 -- -- Driven by encouraging initial safety ...